| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Grant Jerome Alan | Chief Executive Officer, Director | 4225 E. WINDROSE DRIVE, SUITE 200, PHOENIX | /s/ Christopher Kevane, Attorney-in-Fact for Jerome Alan Grant | 02 Mar 2026 | 0001723537 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | UTI | Common Stock, $0.0001 par value | Sale | $2,098,494 | -60,040 | -12% | $34.95 | 430,215 | 27 Feb 2026 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | These shares were sold by the reporting person for personal tax planning purposes. |
| F2 | The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $34.41 to $35.115. The reporting person undertakes to provide the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. |